Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
Molecular markers implicating early malignant events in cervical carcinogenesisHanna-Mari Koskimaa, Kaisa Kurvinen, Silvano Costa, et al.The Journal of Pediatrics|December 6, 2011
Human papillomavirus genotypes present in the oral mucosa of newborns and their concordance with maternal cervical human papillomavirus genotypesHanna-Mari Koskimaa, Tim Waterboer, Michael Pawlita, et al.Viruses|December 23, 2022
Peripheral Blood T-lymphocyte Phenotypes in Mother-Child Pairs Stratified by the Maternal HPV Status: Persistent HPV16 vs. HPV-Negative: A Case-Control StudyHelmi Suominen, Anna Paaso, Hanna-Mari Koskimaa, et al.Journal of Translational Medicine|May 21, 2015
Cell mediated immunity against HPV16 E2, E6 and E7 peptides in women with incident CIN and in constantly HPV-negative women followed-up for 10-yearsAnna Paaso, Hanna-Mari Koskimaa, Marij Jp Welters, et al.Journal of Translational Medicine|November 27, 2015
Human papillomavirus 16-specific cell-mediated immunity in children born to mothers with incident cervical intraepithelial neoplasia (CIN) and to those constantly HPV negativeHanna-Mari Koskimaa, Anna Paaso, Marij J P Welters, et al.Clinical and Experimental Dental Research|January 9, 2021
Interferon-γ and IL-5 associated cell-mediated immune responses to HPV16 E2 and E6 distinguish between persistent oral HPV16 infections and noninfected mucosaAnna Paaso, Hanna-Mari Koskimaa, Marij J P Welters, et al.Journal of Translational Medicine|February 15, 2014
Human papillomavirus 16 E2-, E6- and E7-specific T-cell responses in children and their mothers who developed incident cervical intraepithelial neoplasia during a 14-year follow-up of the Finnish Family HPV cohortHanna-Mari Koskimaa, Anna E Paaso, Marij J P Welters, et al.Pageof 1